Beam Therapeutics (BEAM) Net Equity Issued and Repurchased (2019 - 2026)
Beam Therapeutics (BEAM) posted Net Equity Issued and Repurchased of $2.33 million for Q3 2026, up 38.9% from $1.68 million a year earlier but down 69.1% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Net Equity Issued and Repurchased (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Equity Issued and Repurchased at Beam Therapeutics was $15.27 million, up 67.9% year-over-year; for FY2025, it came in at $7.54 million, down 8.3% from FY2024.
- Annual Net Equity Issued and Repurchased has declined for four consecutive years, with a five-year compound annual growth rate of -47.9% (FY2020 to FY2025).
- In prior years, Beam Therapeutics' Net Equity Issued and Repurchased was $8.22 million in FY2024 (-80.8%), $42.76 million in FY2023 (-62.5%), $114.07 million in FY2022 (-85.1%) and $767.08 million in FY2021 (+292.0%).
- Quarterly Net Equity Issued and Repurchased has run from a low of -$202.22 million in Q4 2023 to a high of $108.34 million in Q2 2023 over five years.
- On a year-over-year basis, Net Equity Issued and Repurchased has increased in each of the last three quarters, with growth averaging 142.8% over the last seven quarters.
- The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q4 2021, with growth of 964.9%; the weakest was Q2 2024, with a decline of 99.8%.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $7.52 million (Q2 2026), $3.54 million (Q1 2026) and $1.89 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Beam Therapeutics | 2.60 Bn | -2.05 Bn | - | 2.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.33 Mn |
| Jun 30, 2026 | 7.52 Mn |
| Mar 31, 2026 | 3.54 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.76 Mn |
| Mar 31, 2025 | 2.22 Mn |
| Dec 31, 2024 | 3.44 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 240,000.00 |
| Mar 31, 2024 | 3.07 Mn |
| Dec 31, 2023 | -202.22 Mn |
| Sep 30, 2023 | 37.56 Mn |
| Jun 30, 2023 | 108.34 Mn |
| Mar 31, 2023 | 99.08 Mn |
| Dec 31, 2022 | 32.66 Mn |
| Sep 30, 2022 | 2.17 Mn |
| Jun 30, 2022 | 23.01 Mn |
| Mar 31, 2022 | 56.24 Mn |
| Dec 31, 2021 | 22.21 Mn |
API Access
Beam Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();